David B. Weiner - Feb 26, 2023 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Director
Signature
/s/ David B. Weiner
Stock symbol
INO
Transactions as of
Feb 26, 2023
Transactions value $
-$14,935
Form type
4
Date filed
2/28/2023, 04:40 PM
Previous filing
Aug 11, 2022
Next filing
Mar 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Options Exercise +11.7K +1.31% 904K Feb 26, 2023 Direct F1
transaction INO Common Stock Options Exercise +11.7K +1.29% 916K Feb 26, 2023 Direct F2
transaction INO Common Stock Sale -$14.9K -11.7K -1.27% $1.28 904K Feb 27, 2023 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Restricted Stock Unit Options Exercise $0 -11.7K -50% $0.00 11.7K Feb 26, 2023 Common Stock 11.7K Direct F1
transaction INO Restricted Stock Unit Options Exercise $0 -11.7K -33.33% $0.00 23.3K Feb 26, 2023 Common Stock 11.7K Direct F2
transaction INO Common Stock Option Award $0 +60K $0.00 60K Feb 27, 2023 Common Stock 60K $1.24 Direct F4
transaction INO Restricted Stock Unit Award $0 +35K $0.00 35K Feb 27, 2023 Common Stock 35K Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2021, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares vested on February 26, 2022; 11,667 shares vested on February 26, 2023; and 11,666 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2022, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares vested on February 26, 2023; 11,667 shares will vest on February 26, 2024; and 11,666 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F3 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 13, 2022.
F4 The vesting schedule for the 60,000 options is as follows: 15,000 shares vested on February 27, 2023; 15,000 shares will vest on February 26, 2024; 15,000 shares will vest on February 26, 2025; and 15,000 shares will vest on February 26, 2026.
F5 Each restricted stock unit represents a contingent right to receive one share of common stock. On February 27, 2023, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares will vest on February 26, 2024; 11,667 shares will vest on February 26, 2025; and 11,666 shares will vest on February 26, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.